Blood test detects pre-Alzheimer’s in Mexican-Americans with 96 percent accuracy
By Jan Jarvis
A blood test developed at UNT Health Science Center detects pre-Alzheimer’s disease in asymptomatic Mexican-Americans with 96 percent accuracy.
The test used blood samples provided by participants in the Health & Aging Brain among Latino Elders (HABLE) study. Hundreds of older Mexican-American residents from the Fort Worth area have participated in this study, which seeks to understand aging in this underserved population.
“These were not people who came into the clinic because they had symptoms of Alzheimer’s,” said Sid O’Bryant, PhD, Director of the Center for Alzheimer’s & Neurodegenerative Disease Research. “These were people in the community whose blood test identified that they had mild memory impairment, which can be pre-Alzheimer’s disease in some people.”
The study further validates UNTHSC research showing a blood test performed as part of a routine physical in a doctor’s office could be used to detect very mild Alzheimer’s – allowing treatment to begin as early as possible. It is especially significant that the blood tests came from participants in the HABLE study, since studies show that Mexican-Americans generally receive their health services in community-based primary care offices, O’Bryant said.
The research, which appears in the Journal of Alzheimer’s Disease, also suggests that blood-based biomarkers for Mexican-Americans may change over time and differ from biomarkers in non-Hispanic whites.
“We think that the biology driving Alzheimer’s may change depending on the stage of the disease,” O’Bryant said.
It is believed that metabolic dysfunction contributes to Alzheimer’s in Mexican-Americans, who are known to have a high incidence of diseases such as diabetes, said Melissa Edwards, M.A., Research Specialist, a University of North Texas graduate student who is the lead author of the study. In non-Hispanic whites, the inflammatory/vascular dysfunction profile is believed to contribute to Alzheimer’s.
But this study showed that inflammation also played a role in pre- Alzheimer’s among Mexican-Americans.
“It could be that inflammation is driving very early memory loss among Mexican Americans,” O’Bryant said. “But once the person has Alzheimer’s, metabolic changes become more important.”
An understanding of the differences in biomarker profiles could make it possible for drugs to be personalized for each patient’s individual needs, O’Bryant said.
“Now we have to figure out who should receive which therapy,” he said. “Anti-inflammatory drugs may be more effective for Mexican-Americans with very early memory loss but diabetes medication may be more appropriate for some patients once they have the disease.”
By Alli Haltom Evonne Kaplan-Liss was struggling with the effects of ulcerative colitis, recovering from surgery and feeling hopeless. “I sank into a deep depression,” said Kaplan-Liss, now a physician and Assistant Dean of Narrative Reflection and Patient Communication for the T...Read more
Apr 23, 2018
By Jeff Carlton The databases of the National Missing and Unidentified Persons System (NamUs) contain files on more than 1,000 active missing person cases in Texas and about 14,000 nationwide – each one a tragedy for the families involved. “I’m not sure we can help a family fin...Read more
Apr 18, 2018
By Alex Branch Rita Patterson, PhD, a UNT Health Science Center Professor, has been inducted into the American Institute for Medical and Biological Engineering College of Fellows, one of the highest professional distinctions for medical and biological engineers. Dr. Patterson was rec...Read more
Apr 16, 2018
By Raul Vintimilla, Department of Pharmacology and Neuroscience I had earned my medical degree and finished a three-year hospital residency in Cuenca, Ecuador when I decided to move my family to the United States. I had discovered during my training that clinical care was not my pass...Read more
Apr 11, 2018